Skip to content
10-Q

Quarterly Report

KINNATE BIOPHARMA INC.

0001140361-23-052465

← back to feed
Filed
Nov 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 3, 2023 47.11M sh
Shares Diluted Q3 2023 · Sep 30, 2023 47.09M sh
Shares Diluted Q3 2023 · Sep 30, 2023 46.39M sh
Shares Diluted Q3 2023 · Sep 30, 2022 44.15M sh
Shares Diluted Q3 2023 · Sep 30, 2022 44.01M sh
Capex Q3 2023 · Sep 30, 2023 $0
Capex Q3 2023 · Sep 30, 2022 $2.63M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$82.68M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$65.29M
Short Term Investments Q3 2023 · Sep 30, 2023 $115.91M
Short Term Investments Q3 2023 · Dec 31, 2022 $172.21M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $51.66M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $29.26M
Stockholders Equity Q3 2023 · Sep 30, 2023 $172.42M
Stockholders Equity Q3 2023 · Jun 30, 2023 $197.62M
Stockholders Equity Q3 2023 · Mar 31, 2023 $222.76M
Stockholders Equity Q3 2023 · Dec 31, 2022 $223.47M
Stockholders Equity Q3 2023 · Sep 30, 2022 $248.34M
Stockholders Equity Q3 2023 · Jun 30, 2022 $273.73M
Stockholders Equity Q3 2023 · Mar 31, 2022 $295.82M
Stockholders Equity Q3 2023 · Dec 31, 2021 $319.48M
Current Liabilities Q3 2023 · Sep 30, 2023 $15.77M
Current Liabilities Q3 2023 · Dec 31, 2022 $17.17M
Total Liabilities Q3 2023 · Sep 30, 2023 $18.29M
Total Liabilities Q3 2023 · Dec 31, 2022 $20.36M
Current Assets Q3 2023 · Sep 30, 2023 $170.3M
Current Assets Q3 2023 · Dec 31, 2022 $230.84M
Total Assets Q3 2023 · Sep 30, 2023 $190.71M
Total Assets Q3 2023 · Dec 31, 2022 $278.83M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.65
Eps Diluted Q3 2023 · Sep 30, 2023 −$2.06
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.70
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.92
Eps Basic Q3 2023 · Sep 30, 2023 −$0.65
Eps Basic Q3 2023 · Sep 30, 2023 −$2.06
Eps Basic Q3 2023 · Sep 30, 2022 −$0.70
Eps Basic Q3 2023 · Sep 30, 2022 −$1.92
Sga Expense Q3 2023 · Sep 30, 2023 $6.61M
Sga Expense Q3 2023 · Sep 30, 2023 $22.51M
Sga Expense Q3 2023 · Sep 30, 2022 $7.82M
Sga Expense Q3 2023 · Sep 30, 2022 $22.88M
Rd Expense Q3 2023 · Sep 30, 2023 $24.51M
Rd Expense Q3 2023 · Sep 30, 2023 $77.4M
Rd Expense Q3 2023 · Sep 30, 2022 $23.55M
Rd Expense Q3 2023 · Sep 30, 2022 $62.96M
Operating Income Q3 2023 · Sep 30, 2023 −$33.09M
Operating Income Q3 2023 · Sep 30, 2023 −$101.88M
Operating Income Q3 2023 · Sep 30, 2022 −$31.37M
Operating Income Q3 2023 · Sep 30, 2022 −$85.84M